Showing results (41-50 of 108) with videos related to
Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routesXuefei Shen, S B Justin Wong, Christopher B Buck, et al.Journal of Virology|June 14, 2013
Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferationJing Li, Xin Wang, Jason Diaz, et al.Journal of Medical Virology|October 26, 2023
Identification of a new polyomavirus in distinct human populations and tissuesCarolina Torres, Rita M Correa, María A Picconi, et al.Virus Evolution|January 28, 2021
Cenote-Taker 2 democratizes virus discovery and sequence annotationMichael J Tisza, Anna K Belford, Guillermo Domínguez-Huerta, et al.Viruses|July 29, 2023
Serology Identifies LIPyV as a Feline Rather than a Human PolyomavirusSergio Kamminga, Els van der Meijden, Patricia Pesavento, et al.Journal of Virology|February 15, 2005
Maturation of papillomavirus capsidsChristopher B Buck, Cynthia D Thompson, Yuk-Ying S Pang, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 6, 2017
Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United StatesGaurav Gupta, Sarat Kuppachi, Roberto S Kalil, et al.Vaccine|December 17, 2009
Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVsTilo Senger, Lysann Schädlich, Sonja Textor, et al.Plos Pathogens|September 15, 2009
Quantitation of human seroresponsiveness to Merkel cell polyomavirusDiana V Pastrana, Yanis L Tolstov, Jürgen C Becker, et al.Plos Pathogens|July 15, 2006
Carrageenan is a potent inhibitor of papillomavirus infectionChristopher B Buck, Cynthia D Thompson, Jeffrey N Roberts, et al.Pageof 11